name: Pear VCstage: introtemperature: warmcheck_size: TBDlast_contact: 2026-02-11next_step: Call Feb 19, 1pm ET
Pear VC
Overview
- Stage focus: Pre-seed / Seed
- Healthcare thesis: Andrew is MD/MBA — strong healthcare lens
- Key people: Andrew Parambath (MD/MBA)
Relationship History
| Date | Type | Notes |
|---|---|---|
| 2026-02-11 | Inbound/scheduling | Call originally scheduled, then rescheduled to Feb 19 at 1pm ET |
Status
- Current stage: Intro — first call scheduled
- Next step: Call Feb 19, 1pm ET
- Temperature: Warm (engaged enough to reschedule rather than cancel)
What They Care About
- TBD — first call pending
- Andrew is MD/MBA — will understand clinical workflows deeply
- Expect clinical detail questions about UM process, not just business model
Prep Notes
- Andrew being MD/MBA is an advantage — can go deep on clinical workflow
- Lead with the clinical problem (appeals arms race, provider AI 1 year ahead)
- Demo if possible — MD investors appreciate seeing the product work
- Have Premera scope ready: auto-auth + appeals, $150/h, production March 1st
- Prepare for clinical depth questions — he'll understand InterQual, PA workflow, etc.